Century Therapeutics focuses on developing allogeneic, iPSC-derived NK and T cell therapies for the treatment of cancer and autoimmune diseases.

Century Therapeutics

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

COM:CENTURYTX

Century Therapeutics

Last Close

1.24

22/11 21:00

Market Cap

102.89M

Beta: -

Volume Today

511.90K

Avg: -

Analysis Not Available